Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico

Emerging Infectious Diseases

Volumn 17, Issue 2, 2011, Pages 283-286

  Ramirez Gonzalez, José Ernesto ^a,b   Gonzalez Duran, Elizabeth ^a,b   Alcantara Perez, Patricia ^a,b   Wong Arambula, Claudia ^a,b   Olivera Diaz, Hiram ^a,b   Cortez Ortiz, Iliana ^a,b   Barrera Badillo, Gisela ^a,b   Nguyen, Ha ^c   Gubareva, Larisa ^c   Lopez Martinez, Irma ^a,b   Díaz Quiñonez, Jose Alberto ^a,b   Lezana Fernández, Miguel Angel ^a,b   Gatell Ramírez, Hugo Lopez ^a,b   Villalobos, Jose Angel Cordova ^a,b   Hernández Avila, Mauricio ^a,b   Alpuche Aranda, Celia ^a,b  

^a Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE DERIVATIVE; HISTIDINE; OSELTAMIVIR; TYROSINE; VIRUS SIALIDASE; ZANAMIVIR;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; MEXICO; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; SCHOOL CHILD; VIRUS GENE;

ADAMANTANE; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MEXICO; MICROBIAL SENSITIVITY TESTS; NEURAMINIDASE; OSELTAMIVIR; PANDEMICS; POINT MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ZANAMIVIR;

EID: 79551620684     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1702.100897     Document Type: Article

References (15)

1. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1). Science. 2009;325:197-201. Epub 2009 May 22.DOI:10.1126/science.1176225
2. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, et al. Origins and evolutionary genomics of the 2009 swineorigin H1N1 influenza A epidemic. Nature. 2009;459:1122-1125.DOI:10.1038/nature08182
3. World Health Organization. Pandemic (H1N1) 2009-update 101. Weekly update [cited 2010 May 21]. http://www.who.int/csr/don/2010_05_21/en/index.html
4. Secretaría de Salud. Estadísticas de la epidemia. Influenza A (H1N1) [cited 2010 May 17]. http://portal.salud.gob.mx/contenidos/noticias/influenza/estadisticas.html
5. Deyde VM, Sheu TG, Trujillo AA, Okomo-Adhiambo M, Garten R, Klimov AI, et al. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob Agents Chemother. 2010;54:1102-1110.DOI: 10.1128/AAC.01417-09
6. Chen H, Cheung CHL, Tai H, Zhao P, Chan JFW, Cheng VCC, et al. Oseltamivir-resistant influenza pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis. 2009;15:1970-1972.DOI: 10.3201/eid1512.091057
7. World Health Organization. Weekly update on oseltamivir resistance to pandemic influenza A (H1N1) 2009 viruses [cited 2010 Apr 14]. http://www.who.int/csr/disease/swineflu/oseltamivirresistant20100416.pdf
8. Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother. 2008;52:3284-3292.DOI: 10.1128/AAC.00555-08
9. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA. 2009;301:1034-1041.DOI: 10.1001/jama.2009.294
10. Hurt AC, Holien JK, Parker M, Kelso A, Barr IG. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol. 2009;83:10366-1073.DOI: 10.1128/JVI.01200-09
11. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, Kawaoka Y, et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and swine origin human influenza A viruses. J Virol. 2009;83:10309-10313.Epub 2009 Jul 15.DOI: 10.1128/JVI.01109-09
12. Kilander A, Rykkvin R, Dudman SG, Hungnes O. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill. 2010;15:pii:19498.
13. Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis. 2001;183:523-531.DOI: 10.1086/318537
14. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis. 2009;15:155-162.DOI: 10.3201/eid1502.081031
15. Centers for Disease Control and Prevention. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:433-435.